0913693 B.C. Ltd. (REPCF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
0913693 B.C. EPS Diluted (Quarterly) : -0.0007 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0007 |
| March 31, 2026 | -0.0005 |
| September 30, 2025 | -0.0002 |
| June 30, 2025 | -0.0006 |
| March 31, 2025 | -0.0015 |
| December 31, 2024 | 0.0058 |
| September 30, 2024 | -0.0022 |
| June 30, 2024 | -0.0022 |
| March 31, 2024 | -0.003 |
| December 31, 2023 | 0.0242 |
| September 30, 2023 | -0.0099 |
| June 30, 2023 | -0.0068 |
| March 31, 2023 | -0.0137 |
| December 31, 2022 | 0.0351 |
| September 30, 2022 | -0.0239 |
| June 30, 2022 | -0.0244 |
| March 31, 2022 | -0.0178 |
| December 31, 2021 | -0.0189 |
| September 30, 2021 | -0.0207 |
| June 30, 2021 | -0.0264 |
| March 31, 2021 | -0.0352 |
| December 31, 2020 | -0.0065 |
| September 30, 2020 | -0.0142 |
| June 30, 2020 | -0.0089 |
| March 31, 2020 | -0.0114 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.0203 |
| September 30, 2019 | -0.0162 |
| June 30, 2019 | -0.0259 |
| March 31, 2019 | -0.0232 |
| December 31, 2018 | -0.0258 |
| September 30, 2018 | -0.0273 |
| June 30, 2018 | -0.0232 |
| March 31, 2018 | -0.0237 |
| December 31, 2017 | -0.0227 |
| September 30, 2017 | -0.0479 |
| June 30, 2017 | -0.0996 |
| March 31, 2017 | -0.0756 |
| December 31, 2016 | -0.1199 |
| September 30, 2016 | -0.0767 |
| June 30, 2016 | -0.0931 |
| March 31, 2016 | -0.1456 |
| December 31, 2015 | -0.1498 |
| September 30, 2015 | -0.1529 |
| June 30, 2015 | -0.244 |
| March 31, 2015 | -0.1612 |
| December 31, 2014 | -0.1761 |
| September 30, 2014 | -0.1838 |
| June 30, 2014 | -0.2751 |
| March 31, 2014 | -0.272 |
| December 31, 2013 | -0.1906 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Easton Pharmaceuticals, Inc. | -- |
| AbCellera Biologics, Inc. | -0.1814 |
| Lifecore Biomedical, Inc. | -0.1897 |
| Codexis, Inc. | -0.1318 |
| Intellipharmaceutics International, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.0517M |
| Revenue (Quarterly) | 0.0639M |
| Total Expenses (Quarterly) | 0.1156M |
| Enterprise Value | 0.7955M |
| Profit Margin (Quarterly) | -80.91% |
| Earnings Yield | -2.00K% |
| Operating Earnings Yield | 2.00K% |
| Normalized Earnings Yield | -2100.00 |